Research Grid raises $6.4M to automate clinical trial admin
Nov 7, 2024
auto_awesome
Amber Hill, founder of Research Grid and a former medical researcher, shares her journey from lab to startup. She discusses her frustrations with administrative tasks in clinical trials and how her company is automating these processes. Listeners will find it fascinating as she highlights the recent $6.4M funding round and the commitment to increasing diversity in trial recruitment. Amber’s vision for revolutionizing clinical trial administration is both inspiring and impactful.
Amber Hill founded Research Grid to automate clinical trial administration, addressing the inefficiencies of outdated software systems in medical research.
The startup secured $6.48 million in seed funding, reflecting the industry's demand for innovative solutions to enhance recruitment and compliance in clinical trials.
Deep dives
Revolutionizing Clinical Trials
A new startup, founded by former medical researcher Amber Hill, aims to enhance the efficiency of clinical trials by automating administrative tasks and data management processes. With the company’s products, Inclusive and Trial Engine, routine tasks such as flagging protocol errors and data extraction can be handled more swiftly, reducing the reliance on outdated software systems that often complicate and delay trials. Hill's venture, Research Grid, secured $6.48 million in seed funding, highlighting the interest in innovative approaches to the challenges faced by the clinical research industry. By streamlining these processes, the startup addresses the critical need for timely recruitment and compliance, particularly in light of the FDA's new diversity requirements for clinical trials.
Entrepreneurial Journey and Challenges
Amber Hill’s journey into entrepreneurship emerged from her frustrations with administrative burdens during her tenure as a medical researcher, leading her to establish Research Grid in 2020. Her experience includes securing initial funding and navigating the challenges of building the company during the COVID-19 pandemic as a solo founder, which proved to be particularly daunting. Despite these hurdles, Hill has propelled the company to achieve significant revenue growth and plans further expansion into markets in the U.S. and Asia. Throughout her journey, she emphasizes the importance of resilience and adaptability, especially as the startup landscape remains competitive and the demand for advanced solutions in clinical research increases.
1.
Revolutionizing Clinical Trials Through Automation